Vanqua Bio
Mr. Silverstein is an Executive Partner at OrbiMed. Jonathan joined OrbiMed in 1999 to focus on private equity and structured transactions in small capitalization public biotechnology and medical device companies. He was previously a Director of Life Sciences in the Investment Banking Department at Sumitomo Bank. Forbes® Magazine named Jonathan one of the top 100 venture capitalists in the world when it placed him on the “Midas List” seven times in the last decade. He holds a J.D. and an M.B.A. from the University of San Diego, and a B.A. in Economics from Denison University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Vanqua Bio
Vanqua Bio is helping usher in a new era of hope for the millions of people living with neurodegenerative diseases. Our unique drug-development approach is designed to overcome longstanding challenges in the neuroscience field by capitalizing on the power of human genetics to identify genes that cause or increase the risk of neurodegenerative disease. We leverage novel, proprietary research tools and in vitro modeling of disease, based on patient-derived neuronal cells, to develop transformative therapies that slow or stop the progression of Parkinson’s disease (PD), Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and Gaucher disease (GD).